Bundesgesundheitsblatt

, Volume 41, Issue 2, pp 78–83 | Cite as

Greutzfeldt-Jakob-Erkrankung (CJK) bzw. humane übertragbare (transmissible) spongiforme Enzephalopathien (TSE)

Bekanntmachungen Robert Koch-Institut — Bundesinstitut für Infektionskrankheiten und nicht Übertragbare Krankheiten
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. [1]
    Gajdusek, D. C.: Infectious amyloids: Subacute spongiform encephalopathies as transmissible cerebral amyloidoses. In: Fields, B. N., Knipe, D. M., Howley, P. M., et al.: Virology (3d edition), Philadelpia: Lippincott-Raven (1996) 2851–2900.Google Scholar
  2. [2]
    Prusiner, S. P.: Prisons. In: Fields, B. N., Knipe, D. M., Howley, P. M., et al.: Virology (3d edition), Philadelpia: Lippincott-Raven (1996) 2901–2950.Google Scholar
  3. [3]
    Diringer, H.: Durchbrechen von Speziesbarrieren mit unkonventionellen Viren. Bundesgesundhbl.33 (1990) 435–440.Google Scholar
  4. [4]
    Chesebro, B., and Fields, B. N.: Transmissible spongiform encephalopathies: a brief introduction. In: Fields, B. N., Knipe, D. M., Howley, P. M., et al.: Virology (3rd edition), Philadelphia: Lippincott-Raven, (1996) 2845–2849.Google Scholar
  5. [5]
    Büeler, H., Aguzzi, A., Sailer, A., Greiner, R. A., Augenried, P., Aguet, M., and Weissmann, C.: Mice devoid of PrP are resistant to scrapie. Cell93 (1993) 1339–1347.CrossRefGoogle Scholar
  6. [6]
    Will, R. G., Ironside, J. W., Zeidler, M., Cousens, S. N., Estibeiro, K., Alperovitch, A., Poser, S., Pocchiari, M., Hofman, A., and Smith, P. G.: A new variant of Creutzfeldt-Jakob disease in the UK. Lancet347 (1996) 921–925.PubMedCrossRefGoogle Scholar
  7. [7]
    Zeidler, M., Stewart, G. E., Barraclough, C. R., Bateman, D.E., Bates, D., Burn, D.J., Colchester, A.C., Durward, W., Fletcher, N. A., Hawkins, S.A., Mackenzie, J. M., and Will, R. G.: New Variant Creutzfeldt-Jacob disease: neurological features and diagnostic tests. Lancet350 (1997) 903–907.PubMedCrossRefGoogle Scholar
  8. [8]
    Chazot, G., Brousolle, E., Lapras, C., Blättler, T., Aguzzi, A., and Kopp, N.: New variant of Creutzfeldt-Jakob disease in a 26-year-old french man. Lancet347 (1996) 1181.PubMedCrossRefGoogle Scholar
  9. [9]
    Collinge, J., Sidle, K. C. L., Meads, J., Ironside, J., and Hill, A. F.: Molecular analysis of prion strain variation and the aetiology of »new variant« CJD. Nature383 (1996) 685–90.PubMedCrossRefGoogle Scholar
  10. [10]
    Bruce, M. E., Will, R. D., Ironside, J. W., McConnell, I., Drummond, D., Suttle, A., McCardle, L., Chree, A., Hope, J., Birkett, C., Cousens, S., Fraser, H., and Bostock, C. J.: Transmissions to mice indicate that »new variant« CJD is caused by the BSE agent. Nature389 (1997) 498–501.PubMedCrossRefGoogle Scholar
  11. [11]
    Hill, A. F., Desbruslais, M., Joiner, S., Sidle, K. T. S., Gowland, I., and Collinge, J.: The same prion strain causes vCJD and BSE. Nature389 (1997) 448–450.PubMedCrossRefGoogle Scholar
  12. [12]
    Brown, P., Preece, M. A., and Will, R. G.: »Friendly fire« in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet340 (1992) 24–27.PubMedCrossRefGoogle Scholar
  13. [13]
    Zerr, I., Bodemer, M., Räcker, S., Grosche, S., Poser, S., Kretzschmar, H. A., and Weber, T.: Cerebrospinal fluid concentration of neuronspecific enolase in diagnosis of Creutzfeldt-Jakob disease. Lancet345 (1995) 1609–1610.PubMedCrossRefGoogle Scholar
  14. [14]
    Hsich, G., Kenney, K., Gibbs, C. J., Lee, K. H., and Harrington, M. G.: The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N. Engl. J. Med.335 (1996) 924–930.PubMedCrossRefGoogle Scholar
  15. [15]
    Simon, D.: Zusammenhänge zwischen menschlichen und tierischen übertragbaren spongiformen Enzephalopathien. RKI InfFo I/97 1–6.Google Scholar
  16. [16]
    Desinfektion und Sterilisation von chirurgischen Instrumenten bei Verdacht auf Creutzfeldt-Jakob-Erkrankungen. Bundesgesundhbl.39 (1996) 282–283.Google Scholar
  17. [17]
    Hill, A. F., Zeidler, M., Ironside, J., and Collinge, J.: Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet349 (1997) 99–100.PubMedCrossRefGoogle Scholar
  18. [18]
    Richtlinien zur Blutgruppenbestimmung und Bluttransfusion (Hämotherapie). Bundesgesundhbl.39 (1996) 468–489.Google Scholar
  19. [19]
    Löwer, J.: Creutzfeldt-Jakob-Erkrankung: Zur Diskussion um das Risiko einer Übertragung durch Blut und Blutprodukte. Bundesgesundhbl.39 (1996) 284–289.Google Scholar
  20. [20]
    Glück, D., Elbert, G., Dengler, T., Gossrau, E., Gräßmann, W., Grimm, M., Holzberger, G., Sternberger, J., Weise, W., und Kubanek, B.: HIV-Lookback-Studie der DRK-Blutspendedienste in der BRD. Infusionsther. Transfusionsmed.21 (1994) 368–375.PubMedGoogle Scholar
  21. [21]
    Ricketts, M. N., Cashman, N. R., Stratton, E. E., and ElSaadany, S.: Is Creutzfeldt-Jakob disease transmitted in blood? Emerging Infectious Diseases3 (1997) 155–163.PubMedCrossRefGoogle Scholar
  22. [22]
    Operskalski, E. A., and Mosley, J. W.: Pooled plasmaderivatives and Creutzfeldt-Jakob disease. Lancet346 (1996) 1223.Google Scholar
  23. [23]
    Brown, P.: Can Creutzfeldt-Jakob disease be transmitted by transfusion? Curr. Opin. Hematol.2 (1995) 472–477.PubMedCrossRefGoogle Scholar
  24. [24]
    Masson, C., Delalande, I., Deslys, J. P., Hénin, D., Fallet-Bianco, C., Dormont, D., and Leys, D.: Creutzfeldt-Jakob disease after pituitaryderived human growth hormone therapy: Two cases with valine 129 homozygous genotype. Neurology44 (1994) 179–180.PubMedGoogle Scholar
  25. [25]
    Créange, A., Gray, F., Cesaro, P., Adle-Biasette, H., Duvoux, C., Cherqui, D., Bell, J., Parchi, P., Gambetti, P., and Degos, J.-D.: Creutzfeldt-Jakob disease after liver transplantation. Ann. Neurol.38 (1995) 269–272.PubMedCrossRefGoogle Scholar
  26. [26]
    Klein, R., and Dumble, L. J.: Transmission of Creutzfeldt-Jakob disease by blood transfusion. Lancet341 (1993) 768.PubMedCrossRefGoogle Scholar
  27. [27]
    Esmonde, T. F. G., Will, R. G., Slattey, J. M., Knight, R., Harries-Jones, R., de Silva, R., and Matthews, W. B.: Creutzfeldt-Jakob disease and blood transfusion. Lancet341 (1993) 205–207.PubMedCrossRefGoogle Scholar
  28. [28]
    Wientjens, D. P. W. M., Davinipour, Z., Hofman, A., Kondo, K., Matthews, W. B., Will, R. G., and van Duijn, C. M.: Risk factors for Creutzfeldt-Jakob disease: a reanalysis of case-control studies. Neurology46 (1996) 1287–1291.PubMedGoogle Scholar
  29. [29]
    Heye, N., Hensen, S., and Müller, N.: Creutzfeldt-Jakob disease and blood transfusion. Lancet343 (1994) 298–299.PubMedCrossRefGoogle Scholar
  30. [30]
    WHO Report of a WHO consultation on medicinal and other products in relation to human and animal transmissible spongiform encephalopathies. WHO/EMC/ZOO/97.3-WHO/BLG/97.2 (1997).Google Scholar

Copyright information

© Springer-Verlag 1998

Personalised recommendations